Capital Advisors »

Ngm Biopharmaceuticals shares owned by Capital Advisors

Quarter-by-quarter ownership of Ngm Biopharmaceuticals (NGM) shares owned by Capital Advisors from 13F filings

Historical chart of Capital Advisors investment in Ngm Biopharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ngm Biopharmaceuticals held by Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ngm Biopharmaceuticals by Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $999 777 1.29
2023-09-30 $999 630 1.59

More positions owned by Capital Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Rus 1000 Grw Etf (IWF)
Caesars Entertainment (CZR)
Vanguard Specialized Funds Div App Etf (VIG)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr Rus 1000 Val Etf (IWD)
Ishares Tr Msci Usa Min Vol (USMV)
Ishares Tr S&p Mc 400gr Etf (IJK)
Spdr Ser Tr S&p Divid Etf (SDY)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Core Div Grwth (DGRO)
Ishares Tr S&p Mc 400vl Etf (IJJ)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Invesco Exch Traded Fd Tr Ii S&p500 Low Vol (SPLV)
Ishares Tr S&p 500 Grwt Etf (IVW)

View all positions for Capital Advisors

Top funds holding Ngm Biopharmaceuticals

Column Group
BlackRock
Vanguard Group
StepStone
Euclidean Capital
Geode Capital Management
Trium Capital
ADAR1 Capital Management
Two Sigma Advisers
Northern Trust
Balyasny Asset Management
Federated Investors
Citadel Advisors
Charles Schwab Investment Management
Goldman Sachs Group

View all funds holding Ngm Biopharmaceuticals